[HTML][HTML] Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease
G D'agostino, R Russo, C Avagliano… - …, 2012 - nature.com
Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid-
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease
G D'Agostino, R Russo… - … publication of the …, 2012 - research.manchester.ac.uk
Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid-
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease.
G D'Agostino, R Russo, C Avagliano… - …, 2012 - iris.unina.it
Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid-
Β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
Β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
[引用][C] Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease
G D'Agostino, R Russo, C Avagliano… - …, 2012 - cir.nii.ac.jp
Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory
Impairment in Mice, an Experimental Model of Alzheimer Disease | CiNii Research CiNii …
Impairment in Mice, an Experimental Model of Alzheimer Disease | CiNii Research CiNii …
[引用][C] Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease
G D'AGOSTINO, R RUSSO… - … (New York, NY), 2012 - pascal-francis.inist.fr
Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory
Impairment in Mice, an Experimental Model of Alzheimer Disease CNRS Inist Pascal-Francis CNRS …
Impairment in Mice, an Experimental Model of Alzheimer Disease CNRS Inist Pascal-Francis CNRS …
[HTML][HTML] Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease
G D'Agostino, R Russo, C Avagliano… - …, 2012 - ncbi.nlm.nih.gov
Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid-
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
Palmitoylethanolamide Protects Against the Amyloid-beta 25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease
G D'Agostino, R Russo, C Avagliano… - …, 2012 - hero.epa.gov
Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid-
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.
G D'Agostino, R Russo, C Avagliano… - … : Official Publication of …, 2012 - europepmc.org
Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid-
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
[PDF][PDF] Palmitoylethanolamide Protects Against the Amyloid-b25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease
G D'Agostino, R Russo, C Avagliano… - …, 2012 - academia.edu
Alzheimer disease (AD) is the most common form of neurodegenerative dementias. AD has
a complex and progressive pathological phenotype characterized by hypometabolism and …
a complex and progressive pathological phenotype characterized by hypometabolism and …
Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease
G D'Agostino, R Russo, C Avagliano… - …, 2012 - abdn.elsevierpure.com
Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid-
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …